GGrantIndex
← Leaderboards

Prince Of Songkla University

Hat Yai, Songkhla

Compare ↔
$2,996,112
Total funding
3
Grants

Funding over time

peak $447.3K · FY200725
$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$2,996,112 · 3

By mechanism

D43$2,676,174 · 1
R21$294,921 · 1
D71$25,017 · 1

Investigators at Prince Of Songkla University

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

Largest grants

TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II$291,211
D43 · FY2022 · TW
TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II$289,737
D43 · FY2023 · TW
TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II$286,869
D43 · FY2024 · TW
TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II$285,484
D43 · FY2025 · TW
TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II$285,391
D43 · FY2021 · TW
TB/MDR-TB Research Capacity Building in LMIC in Southeast Asia$216,000
D43 · FY2018 · TW
TB/MDR-TB Research Capacity Building in LMIC in Southeast Asia$215,999
D43 · FY2016 · TW
TB/MDR-TB Research Capacity Building in LMIC in Southeast Asia$215,999
D43 · FY2019 · TW
TB/MDR-TB Research Capacity Building in LMIC in Southeast Asia$215,999
D43 · FY2015 · TW
TB/MDR-TB Research Capacity Building in LMIC in Southeast Asia$215,921
D43 · FY2017 · TW
Effects of Long Term Use of Antiretroviral Therapy on Oral Innate Immunity$186,921
R21 · FY2008 · DE
TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II: Promotion of Diversity, Equity and Inclusion (DEI)$108,388
D43 · FY2023 · TW
Effects of Long Term Use of Antiretroviral Therapy on Oral Innate Immunity$108,000
R21 · FY2007 · DE
TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II: End-of-Fiscal-Year Supplement$49,176
D43 · FY2023 · TW
Planning Grant for Global Infectious Disease Research Training Program$25,017
D71 · FY2011 · TW